Arkolith/Insider Trading/NLTX/Form 4

Drachman Jonathan G

President and CEO, DirectorNeoleukin Therapeutics, Inc. (NLTX) · full profile →Form 4 · filed Jun 7, 2021
Net Buying
Open-Market Buys
$475K
Open-Market Sells
$0
Net Open-Market Flow
$475K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 4, 2021Buy(P)10K$9.61$96K2.2M
Jun 3, 2021Buy(P)40K$9.48$379K2.2M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-21-038690) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML